(Q42409994)

30 October 2017

0 references

The classics in perspective (English)

1 reference

30 October 2017

1

1 reference

30 October 2017

Subrata Ghosh

2

1 reference

30 October 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

30 October 2017

1 reference

30 October 2017

56

1 reference

30 October 2017

9

1 reference

30 October 2017

1184-1186

1 reference

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954987

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954987

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954987

Infliximab for induction and maintenance therapy for ulcerative colitis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954987

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954987

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954987

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17698863

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17698863

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.2007.121830

1 reference

release_4uk4sx76mzc6rmf4vdr5rqibty

30 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4uk4sx76mzc6rmf4vdr5rqibty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

30 October 2017

PubMed publication ID

17698863

1 reference